Question 1

How much would I have if I DCA'd $100/week into TEVA for 5 years?

Accepted Answer

Dollar cost averaging $100 per week into TEVA for 5 years (261 purchases) would have resulted in a total investment of $26,100 and a current value of $84,662, a return of 224%. Using Enhanced DCA, which concentrates buys during dips, the same $100/week base deployed $34,827 and grew to $150,380 — a 332% return.

Question 2

What is the best DCA strategy for TEVA?

Accepted Answer

Backtesting shows Enhanced DCA — which increases buy amounts during market dips and reduces or skips buys when TEVA is overextended — outperformed standard weekly DCA by 107% over 5 years. The enhanced strategy achieved a 332% return vs 224% for standard DCA.

Question 3

What would $100/week into TEVA be worth after 3 years?

Accepted Answer

Investing $100 per week into TEVA for 3 years (157 purchases, $15,700 total) would have grown to $35,880 — a 129% return. Enhanced DCA over the same period returned 180%.

Question 4

Is DCA into TEVA worth it?

Accepted Answer

Based on a 5-year backtest, DCA into TEVA returned 224% with standard weekly purchases. An intelligent DCA strategy that buys more during dips returned 332% over the same period — a 107% gain in return, while deploying more capital.

Question 5

How many shares of TEVA would I have after DCA for 5 years?

Accepted Answer

Dollar cost averaging $100/week into TEVA for 5 years would result in approximately 2060 shares with a standard DCA approach (avg entry $13). Enhanced DCA targeting dips results in 3659 shares at an average entry of $10.

Question 6

How does TEVA DCA compare to the S&P 500?

Accepted Answer

Enhanced DCA into TEVA returned 332% over the past 5 years. The S&P 500 (SPY) returned approximately 53% over the same period. TEVA's performance reflects its volatility as a healthcare asset. Enhanced DCA outperformed standard DCA by 107%, demonstrating the value of intelligent entry timing during market dips.

Question 7

What is the risk of dollar cost averaging into TEVA?

Accepted Answer

Past backtest performance does not guarantee future results. TEVA is a healthcare asset whose price can fall as well as rise. While DCA reduces timing risk by spreading purchases over time, losses are still possible if the price declines significantly. Always invest within your risk tolerance and consider your overall portfolio diversification.

Question 8

What is the Teva Pharmaceutical Industries Limited dollar cost averaging strategy?

Accepted Answer

Standard DCA invests a fixed amount ($100/week or $433/month) into TEVA at regular intervals. Enhanced DCA improves on this by using RSI (Relative Strength Index) signals to increase buy amounts during market dips (oversold conditions) and reduce or skip purchases when the stock is overextended. Over the 5-year backtest, this timing approach has delivered 107% higher returns than standard DCA while deploying more total capital into TEVA.

Period	Standard DCA	Enhanced DCA	Alpha
1-Year	33%	39%	+6%
3-Year	129%	180%	+52%
5-Year	224%	332%	+107%

TEVA DCA Backtest — Dollar Cost Averaging Results

TEVA DCA Results: Key Findings

Alpha you missed while unsubscribed

Dollar cost averaging into TEVA — backtest results

Buying the dips for Teva Pharmaceutical Industries Limited